Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,547 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
Chat VS, Ellebrecht CT, Kingston P, Gondo G, Bell S, Cordoro KM, Desai SR, Duffin KC, Feldman SR, Garg A, Gelfand JM, Gladman D, Green LJ, Gudjonsson J, Han G, Hawkes JE, Kircik L, Koo J, Langley R, Lebwohl M, Michael Lewitt G, Liao W, Martin G, Orbai AM, Reddy SM, Richardson V, Ritchlin CT, Schwartzman S, Siegel EL, Van Voorhees AS, Wallace EB, Weinberg JM, Winthrop KL, Yamauchi P, Armstrong AW. Chat VS, et al. Among authors: koo j. J Am Acad Dermatol. 2024 Jun;90(6):1170-1181. doi: 10.1016/j.jaad.2023.12.070. Epub 2024 Feb 7. J Am Acad Dermatol. 2024. PMID: 38331098
Topical therapy for psoriasis.
Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Lebwohl M, et al. Among authors: koo j. Int J Dermatol. 1995 Oct;34(10):673-84. Int J Dermatol. 1995. PMID: 8537153 Review. No abstract available.
Cyclosporine as maintenance therapy in patients with severe psoriasis.
Shupack J, Abel E, Bauer E, Brown M, Drake L, Freinkel R, Guzzo C, Koo J, Levine N, Lowe N, McDonald C, Margolis D, Stiller M, Wintroub B, Bainbridge C, Evans S, Hilss S, Mietlowski W, Winslow C, Birnbaum JE. Shupack J, et al. Among authors: koo j. J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):423-32. doi: 10.1016/s0190-9622(97)80219-8. J Am Acad Dermatol. 1997. PMID: 9091474 Free article. Clinical Trial.
Duration of remission of psoriasis therapies.
Koo J, Lebwohl M. Koo J, et al. J Am Acad Dermatol. 1999 Jul;41(1):51-9. doi: 10.1016/s0190-9622(99)70406-8. J Am Acad Dermatol. 1999. PMID: 10411411 Review.
Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?
Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Krueger GG, et al. Among authors: koo j. J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):281-5. doi: 10.1067/mjd.2000.106374. J Am Acad Dermatol. 2000. PMID: 10906652
Tazarotene plus UVB phototherapy in the treatment of psoriasis.
Koo JY, Lowe NJ, Lew-Kaya DA, Vasilopoulos AI, Lue JC, Sefton J, Gibson JR. Koo JY, et al. J Am Acad Dermatol. 2000 Nov;43(5 Pt 1):821-8. doi: 10.1067/mjd.2000.107940. J Am Acad Dermatol. 2000. PMID: 11050587 Clinical Trial.
2,547 results